Sernova Corp.

Sernova Corp.

SEOVF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$24.55M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sernova Corp.Sernova Corp.-3.7-88%--0.2
$-0.04

Current Fair Value

155.8% downside

Overvalued by 155.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$24.55 Million
Enterprise Value$27.07 Million
Earnings per Share$-0.05
Beta0.64
Outstanding Shares377,642,509

Return

Return on Equity87.53%ROE
Return on Assets-2750.96%
Return on Invested Capital77.79%

Valuation & Multiples

P/E Ratio-3.74P/E Ratio
PEG9.87PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.07Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-2.98
Enterprise Value to Net Income-3
Total Debt to Enterprise0.1
Debt to Equity-0.22Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 10, 2026
EPS
-$0.01
Est. -$0.01
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
December 17, 2026
EPS Estimate
-$0.01
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Sernova Corp.

8 employees
CEO: Jonathan N. Rigby

Sernova Corp. is a Canadian firm, established in 1998 and headquartered in London, that specializes in advanced regenerative medicine therapeutics and is currently in its clinical development phase. The company's primary objective is to ...